Since the balance between canonical and alternative NF-κB signaling and the resulting chemokine patterns regulate multiple aspects of cancer cell and TME biology, our data imply the activation status of T cells in the TME is relevant to both their killing of cancer cells and to their TME remodeling functions. The gene discussed is NFKB1; the disease is cancer.